scholarly article | Q13442814 |
P356 | DOI | 10.1002/1521-4141(2000012)30:12<3522::AID-IMMU3522>3.0.CO;2-D |
P698 | PubMed publication ID | 11093172 |
P2093 | author name string | D Segal | |
C J Cohen | |||
Y Reiter | |||
A F Kirkin | |||
G Denkberg | |||
P2860 | cites work | Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers | Q27485114 |
Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 | ||
Creating and engineering human antibodies for immunotherapy | Q30874943 | ||
Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity | Q36142259 | ||
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes | Q36401622 | ||
Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli | Q36647585 | ||
A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. | Q36807094 | ||
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides | Q36954248 | ||
A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity | Q37291950 | ||
Peptides naturally presented by MHC class I molecules | Q40898177 | ||
The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire | Q40908102 | ||
Serial triggering of many T-cell receptors by a few peptide-MHC complexes | Q41346263 | ||
Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic | Q41373011 | ||
Cancer vaccines based on the identification of genes encoding cancer regression antigens | Q41459252 | ||
The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide | Q41640226 | ||
T cell defined tumor antigens | Q41642406 | ||
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients | Q41672999 | ||
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo | Q41764334 | ||
Production of soluble MHC class II proteins with covalently bound single peptides | Q42068482 | ||
Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules | Q43655210 | ||
Virus-specific CD8+ T cells in primary and secondary influenza pneumonia | Q45755057 | ||
Ligand recognition by alpha beta T cell receptors | Q46222293 | ||
Studies on fibronectin and its domains. II. Secondary structure and spatial configuration of fibronectin and of its domains. | Q50783798 | ||
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. | Q52040367 | ||
The repertoire of T cells shaped by a single MHC/peptide ligand. | Q52887226 | ||
Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. | Q53436850 | ||
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA | Q56930699 | ||
From TCR Engagement to T Cell Activation | Q57363708 | ||
Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain | Q72797887 | ||
HLA-peptide tetrameric complexes | Q77174550 | ||
Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis | Q77768045 | ||
High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling | Q77769114 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
refolding | Q3935998 | ||
P304 | page(s) | 3522-3532 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | European Journal of Immunology | Q5412727 |
P1476 | title | Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens. | |
P478 | volume | 30 |
Q33357299 | Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts |
Q37789411 | Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes |
Q34035564 | Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity. |
Q46187873 | Greater expression of TLR2, TLR4, and IL6 due to negative energy balance is associated with lower expression of HLA-DRA and HLA-A in bovine blood neutrophils after intramammary mastitis challenge with Streptococcus uberis |
Q34510727 | HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells |
Q34718365 | Hematopoietic cellular therapy: implications for the flow cytometry laboratory |
Q33816520 | Mammary gene expression profiles during an intramammary challenge reveal potential mechanisms linking negative energy balance with impaired immune response |
Q78555137 | Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes |
Q31005351 | Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions |
Q33368725 | Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy |
Q44473369 | Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHC. |
Q36297606 | T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. |
Q37987723 | T-cell-receptor-like antibodies - generation, function and applications |
Q37192915 | Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies |
Q34834369 | Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo |
Search more.